English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Summary  Data are presented to demonstrate the advantages of Marcumar in short-term and long-term treatment, over less active anticoagulants, and the effectiveness of Konakion as regulator of such therapy.

thrombosis and haemostasis

Oral Anticoagulant Therapy and its Control: Marcumar (Phenprocoumon), a new highly active Anticoagulant and Konakion (Phytomenadione), as an Effective Regulator